CPH creso pharma limited

Creso Pharma (ASX:CPH) shares jump on record revenue growth

  1. 7,927 Posts.
    lightbulb Created with Sketch. 1230
    • Creso Pharma (CPH) has reported its second consecutive quarter of record revenue growth, reaching just over $1.7 million in the quarter ending June 30
    • This is a 24 per cent increase over the last quarter and a 451 per cent increase over the previous corresponding period
    • The growth has come from strong demand for Creso's animal and human health CBD products as well as craft cannabis products from its Canadian subsidiary

    Read the Full Article on The Market Herald here
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.